Neurocrine Biosciences (NASDAQ:NBIX) Lowered to “Buy” Rating by StockNews.com
StockNews.com lowered shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday. NBIX has been the subject of a number of other research reports. Bank of America decreased their price objective on shares of Neurocrine Biosciences from $184.00 to $179.00 […]
StockNews.com lowered shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday. NBIX has been the subject of a number of other research reports. Bank of America decreased their price objective on shares of Neurocrine Biosciences from $184.00 to $179.00 […]
